Events | 2015.11.05
Quad Technologies Launches Fully Releasable Cell Separation Solution for Enhanced Cell Purity and Viability Following Successful Investment Round
WOBURN, Mass.--(BUSINESS WIRE)--The most promising areas of translational medical research, including CAR-T cancer therapies and stem cell-based regenerative medicine, require the isolation and purification of large numbers of viable, functional cells. There is growing demand from researchers and clinicians for technologies that provide high viability, enhanced efficiency and scalability to optimize conventional cell separation techniques. Quad Technologies Inc (“Quad”), developer of a novel ce
For more information, please visit
http://www.businesswire.com/news/home/20[...]lly-Releasable-Cell-Separation
